Intra-Cellular Therapies, Inc. (ITCI) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Intra-Cellular Therapies, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 05/09/2025 9.52 M $1.26 B   -2.07% 9.23%
BLACKROCK, INC. 05/02/2025 8.75 M $1.15 B   43.23% 8.49%
PENTWATER CAPITAL MANAGEMENT LP 05/15/2025 5.19 M $684.66 M   100.00% 5.03%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 05/15/2025 3.49 M $459.75 M   100.00% 3.38%
UBS OCONNOR LLC 05/15/2025 3.09 M $407.78 M   15,139.27% 3.00%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2025 3.06 M $403.02 M   100.00% 2.96%
FMR LLC 05/12/2025 2.66 M $351.21 M   -75.96% 2.58%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 2.26 M $297.86 M   1,516.72% 2.19%
CITADEL ADVISORS LLC 05/15/2025 2.24 M $295.12 M   1,795.54% 2.17%
DEEP TRACK CAPITAL, LP 05/15/2025 2.00 M $263.84 M   0.00% 1.94%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.83 M $241.74 M   6.71% 1.78%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.82 M $239.47 M   398.20% 1.76%
STATE STREET CORP 05/15/2025 1.78 M $234.99 M   -4.99% 1.73%
WEISS ASSET MANAGEMENT LP 05/15/2025 1.64 M $216.35 M   100.00% 1.59%
UBS GROUP AG 05/13/2025 1.59 M $209.80 M   2,064.65% 1.54%
GLAZER CAPITAL, LLC 05/15/2025 1.58 M $208.39 M   100.00% 1.53%
GOLDMAN SACHS GROUP INC 05/16/2025 1.47 M $194.42 M   291.52% 1.43%
MORGAN STANLEY 05/15/2025 1.40 M $185.14 M   57.26% 1.36%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2025 1.09 M $144.29 M   100.00% 1.06%
TIG ADVISORS, LLC 05/15/2025 1.06 M $139.56 M   100.00% 1.03%
LMR PARTNERS LLP 05/15/2025 991.10 K $130.75 M   100.00% 0.96%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 931.33 K $122.86 M   267.10% 0.90%
D. E. SHAW & CO., INC. 05/15/2025 923.81 K $121.87 M   72.85% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 895.66 K $118.16 M   -1.21% 0.87%
LMR PARTNERS LLP 05/15/2025 863.13 K $113.86 M   10,455.63% 0.84%
MILLENNIUM MANAGEMENT LLC 05/15/2025 844.07 K $111.35 M   62.06% 0.82%
PERCEPTIVE ADVISORS LLC 05/15/2025 786.36 K $103.74 M   -38.96% 0.76%
JPMORGAN CHASE & CO 05/12/2025 759.99 K $100.26 M   -85.17% 0.74%
KRYGER CAPITAL LTD 05/15/2025 750.57 K $99.02 M   100.00% 0.73%
FIRST TRUST CAPITAL MANAGEMENT L.P. 05/15/2025 719.55 K $94.92 M   100.00% 0.70%
ALPINE ASSOCIATES MANAGEMENT INC. 05/08/2025 719.50 K $94.92 M   100.00% 0.70%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 700.90 K $92.46 M   -51.29% 0.68%
DEUTSCHE BANK AG\ 05/09/2025 693.43 K $91.48 M   -10.64% 0.67%
NEXPOINT ASSET MANAGEMENT, L.P. 05/15/2025 691.28 K $91.19 M   100.00% 0.67%
FIRST TRUST ADVISORS LP 05/14/2025 663.92 K $87.58 M   -13.34% 0.64%
NORTHERN TRUST CORP 05/13/2025 634.54 K $83.71 M   4.06% 0.62%
AVORO CAPITAL ADVISORS LLC 05/15/2025 625.00 K $82.45 M   -79.51% 0.61%
TUDOR INVESTMENT CORP ET AL 05/15/2025 621.82 K $82.03 M   100.00% 0.60%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 621.20 K $81.95 M   97.52% 0.60%
MAN GROUP PLC 05/15/2025 620.70 K $81.88 M   1,177.24% 0.60%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 606.81 K $80.05 M   832.85% 0.59%
FIL LTD 05/12/2025 568.00 K $74.93 M   100.00% 0.55%
AMUNDI 05/15/2025 561.27 K $74.01 M   20,466.73% 0.54%
BERYL CAPITAL MANAGEMENT LLC 05/15/2025 541.64 K $71.45 B   100.00% 0.53%
READYSTATE ASSET MANAGEMENT LP 05/06/2025 507.20 K $66.91 M   100.00% 0.49%
WESTCHESTER CAPITAL MANAGEMENT, LLC 05/14/2025 460.27 K $60.72 M   100.00% 0.45%
LMR PARTNERS LLP 05/15/2025 450.00 K $59.36 M   100.00% 0.44%
TACONIC CAPITAL ADVISORS LP 05/15/2025 443.70 K $58.53 M   100.00% 0.43%
TWIN SECURITIES, INC. 05/15/2025 440.69 K $58.14 M   100.00% 0.43%
MARSHALL WACE, LLP 05/15/2025 440.67 K $58.13 M   -59.19% 0.43%

Intra-Cellular Therapies, Inc. institutional Ownership - FAQ's

During the previous two years, 590 institutional investors and hedge funds held shares of Intra-Cellular Therapies, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 9.52 M

BlackRock, Inc.: 8.75 M

Pentwater Capital Management LP: 5.19 M

DAVIDSON KEMPNER CAPITAL MANAGEMENT LP: 3.49 M

UBS OCONNOR LLC: 3.09 M

FARALLON CAPITAL MANAGEMENT LLC: 3.06 M

92.31% of Intra-Cellular Therapies, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 114.95 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.